Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.44 -0.05 (-0.58%)
As of: Nov 11, 2026 · 9:47 AM EST

Syndax Pharmaceuticals (SNDX) Preferred Stock Liabilities (2015)

Updated

Syndax Pharmaceuticals' Preferred Stock Liabilities came in at $319.11 million for Q4 2015.

Analysis

Syndax Pharmaceuticals (SNDX) Preferred Stock Liabilities (2015) Analysis & Trends

  • Going back by year, Preferred Stock Liabilities was $146.85 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 319.11 Mn
API Access

Syndax Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SNDX&period=max&api_key=YOUR_API_KEY